These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 16575264
21. Management of severe sphincterotomy bleeding with recombinant activated factor VII. Garrido-Serrano A. Gastrointest Endosc; 2012 Oct; 76(4):925-6. PubMed ID: 22985655 [No Abstract] [Full Text] [Related]
24. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. Franchini M, Lippi G, Franchi M. BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855 [Abstract] [Full Text] [Related]
25. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. Wissa I, Ebeid E, El-Shawarby S, Chandakas S, Kamal T, Hill N. J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490 [Abstract] [Full Text] [Related]
26. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P. Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152 [Abstract] [Full Text] [Related]
28. Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant activated factor VII. Celkan T, Alhaj S, Civilibal M, Elicevik M. Pediatr Hematol Oncol; 2007 Mar; 24(2):117-21. PubMed ID: 17454777 [Abstract] [Full Text] [Related]
29. Use of recombinant activated factor VII in children. Hammer GB, Williams GD. Paediatr Anaesth; 2007 Dec; 17(12):1123-5. PubMed ID: 17986029 [No Abstract] [Full Text] [Related]
32. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Verre M, Bossio F, Mammone A, Piccirillo M, Tancioni F, Varano M. Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374 [Abstract] [Full Text] [Related]
33. Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins. Culić S, Kuljis D, Armanda V, Jankovic S. Pediatr Blood Cancer; 2007 Sep; 49(3):332-5. PubMed ID: 16514611 [Abstract] [Full Text] [Related]
34. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients. Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N. Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596 [No Abstract] [Full Text] [Related]
35. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A. Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616 [Abstract] [Full Text] [Related]